Hawkins SA - Search Results

1

Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase.

Shurtleff SA, Downing JR, Rock CO, Hawkins SA, Roussel MF, Sherr CJ. Shurtleff SA, et al. Among authors: hawkins sa. EMBO J. 1990 Aug;9(8):2415-21. doi: 10.1002/j.1460-2075.1990.tb07417.x. EMBO J. 1990. PMID: 2164469 Free PMC article.

2

Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain.

van Daalen Wetters T, Hawkins SA, Roussel MF, Sherr CJ. van Daalen Wetters T, et al. Among authors: hawkins sa. EMBO J. 1992 Feb;11(2):551-7. doi: 10.1002/j.1460-2075.1992.tb05086.x. EMBO J. 1992. PMID: 1531631 Free PMC article.

3

Methylprednisolone-induced neutrophil leukocytosis--down-modulation of neutrophil L-selectin and Mac-1 expression and induction of granulocyte-colony stimulating factor.

Crockard AD, Boylan MT, Droogan AG, McMillan SA, Hawkins SA. Crockard AD, et al. Among authors: hawkins sa. Int J Clin Lab Res. 1998;28(2):110-5. doi: 10.1007/s005990050029. Int J Clin Lab Res. 1998. PMID: 9689553

4

CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis.

Crockard AD, Treacy MT, Droogan AG, Hawkins SA. Crockard AD, et al. Among authors: hawkins sa. J Neurol. 1996 Jun;243(6):475-81. doi: 10.1007/BF00900503. J Neurol. 1996. PMID: 8803822

5

Methylprednisolone attenuates interferon-beta induced expression of HLA-DR on monocytes.

Crockard AD, Treacy MT, Droogan AG, Hawkins SA. Crockard AD, et al. Among authors: hawkins sa. J Neuroimmunol. 1996 Oct;70(1):29-35. doi: 10.1016/s0165-5728(96)00100-2. J Neuroimmunol. 1996. PMID: 8862132

6

Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis.

Crockard AD, Treacy MT, Droogan AG, McNeill TA, Hawkins SA. Crockard AD, et al. Among authors: hawkins sa. Mult Scler. 1995 Apr;1(1):20-4. doi: 10.1177/135245859500100104. Mult Scler. 1995. PMID: 9345465

7

Effects of intravenous methylprednisolone therapy on leukocyte and soluble adhesion molecule expression in MS.

Droogan AG, Crockard AD, McMillan SA, Hawkins SA. Droogan AG, et al. Among authors: hawkins sa. Neurology. 1998 Jan;50(1):224-9. doi: 10.1212/wnl.50.1.224. Neurology. 1998. PMID: 9443484 Clinical Trial.

8

Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis.

McDonnell GV, McMillan SA, Douglas JP, Droogan AG, Hawkins SA. McDonnell GV, et al. Among authors: hawkins sa. J Neuroimmunol. 1998 May 15;85(2):186-92. doi: 10.1016/s0165-5728(98)00009-5. J Neuroimmunol. 1998. PMID: 9630167

9

Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis.

McMillan SA, McDonnell GV, Douglas JP, Droogan AG, Hawkins SA. McMillan SA, et al. Among authors: hawkins sa. Neurology. 1998 Oct;51(4):1156-60. doi: 10.1212/wnl.51.4.1156. Neurology. 1998. PMID: 9781547

10

Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease.

McDonnell GV, McMillan SA, Douglas JP, Droogan AG, Hawkins SA. McDonnell GV, et al. Among authors: hawkins sa. J Neurol. 1999 Feb;246(2):87-92. doi: 10.1007/s004150050313. J Neurol. 1999. PMID: 10195402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters